Global Peripheral Artery Disease Market Report 2024

Peripheral Artery Disease Global Market Report 2024 – By Type (Peripheral Angioplasty Balloons, Peripheral Stents, Peripheral Catheters, Inferior Vena Cava (IVC) Filters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Peripheral Accessories), By Drugs (Lipid-Lowering Drugs, Blood Pressure Lowering Drugs, Glucose Regulating Drugs, Blood Clot Preventing Drugs, Inotropes, Thrombolytics Agents, Anti-Inflammatory Agents), By Route of Administration (Oral, Parenteral, Other Routes of Administration), By End Users (Hospitals, Specialty Clinics, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033

Peripheral Artery Disease Global Market Report 2024

Starting Price : $5000.00 $4000.00 | Pages : | Published : October 2024 | Delivery Time: 2-3 business days | Format : pdf

Need assistance or more information before the purchase?

Enquire Before Buying
Peripheral Artery Disease Global Market Report 2024

Proud Members Of

checkslacipN checkaoirsN checkscipN

Peripheral Artery Disease Market Definition

Peripheral artery disease (PAD) is a disorder that causes the arteries that carry blood to the limbs, most commonly the legs, to thin or block. It is usually caused by atherosclerosis, characterized by the accumulation of fatty deposits (plaques) inside the artery walls, resulting in decreased blood flow to the afflicted regions.

The main peripheral artery disease products are peripheral angioplasty balloons, peripheral stents, peripheral catheters, inferior vena cava (IVC) filters, plaque modification devices, hemodynamic flow alteration devices, and peripheral accessories. Peripheral angioplasty balloons refer to medical devices designed to dilate narrowed or blocked peripheral arteries and it is used in peripheral artery disease to open narrowed or blocked arteries by inflating the balloon to compress the plaque and widen the artery, restoring blood flow. The various drugs used are lipid-lowering drugs, blood pressure-lowering drugs, glucose-regulating drugs, blood clot-preventing drugs, inotropes, thrombolytics agents, and anti-inflammatory agents that are administered through different routes of administration such as oral, parenteral, and others by different end users such as hospitals, specialty clinics, and others.

Peripheral Artery Disease Market Segmentation

The peripheral artery disease market covered in this report is segmented –

1) By Type: Peripheral Angioplasty Balloons, Peripheral Stents, Peripheral Catheters, Inferior Vena Cava (IVC) Filters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Peripheral Accessories

2) By Drugs: Lipid-Lowering Drugs, Blood Pressure Lowering Drugs, Glucose Regulating Drugs, Blood Clot Preventing Drugs, Inotropes, Thrombolytics Agents, Anti-Inflammatory Agents

3) By Route of Administration: Oral, Parenteral, Other Routes of Administration

4) By End Users: Hospitals, Specialty Clinics, Other End Users

Global Peripheral Artery Disease Market Size 2023 to 2028: Graph

Peripheral Artery Disease Market Size 2024 And Growth Rate

The peripheral artery disease market size has grown strongly in recent years. It will grow from $3.97 billion in 2023 to $4.28 billion in 2024 at a compound annual growth rate (CAGR) of 7.9%. The growth in the historic period can be attributed to increasing prevalence of risk factors, growing aging population, clinical research and evidence-based medicine, awareness and screening programs, government healthcare initiatives..

Peripheral Artery Disease Market Growth Forecast

The peripheral artery disease market size is expected to see strong growth in the next few years. It will grow to $5.67 billion in 2028 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to focus on patient-centric care, advancements in minimally invasive procedures, digital health and remote monitoring, regenerative medicine approaches, targeted drug therapies.. Major trends in the forecast period include health equity initiatives, integration of wearable devices, expansion of home-based rehabilitation, patient-reported outcomes (pros), shift to outpatient settings..

Peripheral Artery Disease Market Driver: Rising Prevalence Of Peripheral Artery Diseases Expected To Drive Growth In Peripheral Artery Disease Market

The rise in the prevalence of peripheral artery diseases is expected to propel the growth of the peripheral artery disease market going forward. Peripheral artery disease refers to the narrowing or blockage of arteries outside the heart, usually in the legs, resulting in reduced blood flow and potential complications. Peripheral artery disease treatment helps reduce peripheral artery disease symptoms, enhance mobility, and decrease the risk of severe complications that improve patients' well-being. For instance, in April 2023, according to HMP Communications LLC, a US-based patient-centered education resource, the global prevalence of peripheral artery disease increased from 11.3 million in 1995 to 21 million in 2020 and estimated to reach 23.8 million by 2030. Therefore, the rise in the prevalence of peripheral artery diseases is driving the growth of the peripheral artery disease market.

Peripheral Artery Disease Market Driver: Rising Aging Population Set To Fuel Growth In Peripheral Artery Disease Market

An increase in the size of the aging population is expected to drive the growth of the peripheral artery disease market going forward. An aging population refers to a situation where the proportion of older people in a population is steadily increasing. As individuals age, they are more likely to develop atherosclerosis, a major risk factor for PAD. This condition occurs when arteries become narrowed or blocked due to the buildup of fatty deposits, leading to reduced blood flow to the limbs. For example, in October 2022, according to the World Health Organization, by 2030, 1 in 6 people in the world will be aged 60 years or older. At this time, the share of the population aged 60 years and over will increase from 1 billion in 2020 to 1.4 billion. By 2050, the world’s population of people aged 60 years and older will double (2.1 billion). The number of people aged 80 years or older is expected to triple between 2020 and 2050 to reach 426 million. Therefore, the aging population is expected to drive demand for the peripheral artery disease market.

Global Peripheral Artery Disease Market Major Players

Major companies operating in the peripheral artery disease market report are Cardinal Health Inc., Vascular Solutions Inc., Bayer AG, Abbott Laboratories, Medtronic plc., Koninklijke Philips N.V. (Royal Philips), B. Braun Melsungen AG., Terumo Corporation, Edwards Lifesciences, Becton Dickinson and Company (BD), Boston Scientific Corporation Incorporated, Cook Group Incorporated, Merit Medical Systems Inc., NuVasive Inc., Arjo AB, Penumbra Inc., BIOTRONIK SE and Co. KG, Natus Medical Inc., AngioDynamics Inc., Shockwave Medical Inc., Cardiovascular Systems Inc., Endologix LLC., LeMaitre Vascular Inc., Silk Road Medical Inc., WL Gore and Associates Inc., MicroPort Scientific Corporation, Bard Peripheral Vascular Inc., Lombard Medical Inc., Avinger Inc., Ra Medical Systems Inc.

Global Peripheral Artery Disease Market Trend: Technologically Advanced Solution For Peripheral Artery Disease Treatment

Technological advancements are a key trend gaining popularity in the peripheral artery disease market. Major companies operating in the peripheral artery disease market are adopting technologically advanced surgery treatments to sustain their position in the market. For instance, in November 2022, Genesis MedTech Group, a Singapore-based medical device company, introduced chocolate touch paclitaxel DCB catheter, a percutaneous transluminal angioplasty (PTA) catheter for the treatment of patients with superficial femoral artery and popliteal artery disease. The Chocolate Touch drug-coated balloon is the first and only balloon catheter in the device that combines therapeutic agent administration with a next-generation angioplasty platform for treating peripheral artery disease. It uses pillow-like structures covered with a therapeutic chemical to open in tiny parts to offer an alternate therapy to standard drug-coated balloon angioplasty for individuals suffering from peripheral artery disease. As a result, the balloon surface increases, allowing for more effective medication delivery to the vessel wall and eliminating the requirement for permanent implants.

Global Peripheral Artery Disease Market Trend: Rising Obesity Rates Fuel Growth Of Peripheral Artery Disease Market

Increasing obesity rates are expected to propel the growth of the peripheral artery disease market. Obesity refers to a medical condition characterized by an excess accumulation of body fat to the extent that it may have a negative impact on health. Obesity is a significant factor that contributes to the development of peripheral artery disease (PAD), a condition in which the blood vessels that supply blood to the legs become narrowed or blocked, causing pain and difficulty walking. For instance, in May 2022, according to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a US-based National Institute of Health (NIH), more than 2 in 5 adults (42.4%) have obesity, and about 1 in 11 adults (9.2%) have severe obesity. Therefore, the increasing obesity rates are driving the peripheral artery disease market.

Peripheral Artery Disease Market Merger And Acquisition: Abbott Laboratories Expands Peripheral Artery Disease Portfolio With Acquisition Of Cardiovascular Systems Inc

In April 2023, Abbott Laboratories, a US-based medical device company, acquired Cardiovascular Systems Inc. for an undisclosed amount. This acquisition broadens, diversifies, and enriches Abbott’s peripheral and coronary artery disease portfolio by adding the innovative atherectomy system from Cardiovascular Systems Inc. Cardiovascular Systems Inc is a US-based medical device company involved in manufacturing peripheral artery disease products.

Regional Outlook For The Global Peripheral Artery Disease Market

North America was the largest region in the peripheral artery disease market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the peripheral artery disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the peripheral artery disease market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The peripheral artery disease market consists of revenues earned by entities by providing peripheral artery disease management services and therapies such as diagnosis, angioplasty, atherectomy, lithoplasty, endovascular, vascular surgery, and rehabilitation. The market value includes the value of related goods sold by the service provider or included within the service offering. The peripheral artery disease market also includes sales of guidewires, bare metal, drug-eluting, compression stockings, and exercise equipment. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The peripheral artery disease market research report is one of a series of new reports from The Business Research Company that provides peripheral artery disease market statistics, including peripheral artery disease industry global market size, regional shares, competitors with a peripheral artery disease market share, detailed peripheral artery disease market segments, market trends and opportunities, and any further data you may need to thrive in the peripheral artery disease industry. This peripheral artery disease market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Peripheral Artery Disease Market Report Forecast And Analysis
Report AttributeDetails
Market Size Value In 2024 $4.28 billion
Revenue Forecast In 2033 $5.67 billion
Growth Rate CAGR of 7.3% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Type: Peripheral Angioplasty Balloons, Peripheral Stents, Peripheral Catheters, Inferior Vena Cava (IVC) Filters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Peripheral Accessories
2) By Drugs: Lipid-Lowering Drugs, Blood Pressure Lowering Drugs, Glucose Regulating Drugs, Blood Clot Preventing Drugs, Inotropes, Thrombolytics Agents, Anti-Inflammatory Agents
3) By Route of Administration: Oral, Parenteral, Other Routes of Administration
4) By End Users: Hospitals, Specialty Clinics, Other End Users
Regional Scope Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Additional countries that can be covered in the report for an additional fee: Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Cardinal Health Inc.; Vascular Solutions Inc.; Bayer AG; Abbott Laboratories; Medtronic plc.; Koninklijke Philips N.V. (Royal Philips); B. Braun Melsungen AG.; Terumo Corporation; Edwards Lifesciences; Becton Dickinson and Company (BD); Boston Scientific Corporation Incorporated; Cook Group Incorporated; Merit Medical Systems Inc.; NuVasive Inc.; Arjo AB; Penumbra Inc.; BIOTRONIK SE and Co. KG; Natus Medical Inc.; AngioDynamics Inc.; Shockwave Medical Inc.; Cardiovascular Systems Inc.; Endologix LLC.; LeMaitre Vascular Inc.; Silk Road Medical Inc.; WL Gore and Associates Inc.; MicroPort Scientific Corporation; Bard Peripheral Vascular Inc.; Lombard Medical Inc.; Avinger Inc.; Ra Medical Systems Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Peripheral Artery Disease Market Characteristics

    3. Peripheral Artery Disease Market Trends And Strategies

    4. Peripheral Artery Disease Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On The Market

    4.2. Ukraine-Russia War Impact On The Market

    4.3. COVID-19 Impact On The Market

    5. Global Peripheral Artery Disease Market Size and Growth

    5.1. Global Peripheral Artery Disease Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global Peripheral Artery Disease Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global Peripheral Artery Disease Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. Peripheral Artery Disease Market Segmentation

    6.1. Global Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Peripheral Angioplasty Balloons

    Peripheral Stents

    Peripheral Catheters

    Inferior Vena Cava (IVC) Filters

    Plaque Modification Devices

    Hemodynamic Flow Alteration Devices

    Peripheral Accessories

    6.2. Global Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Lipid-Lowering Drugs

    Blood Pressure Lowering Drugs

    Glucose Regulating Drugs

    Blood Clot Preventing Drugs

    Inotropes

    Thrombolytics Agents

    Anti-Inflammatory Agents

    6.3. Global Peripheral Artery Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Oral

    Parenteral

    Other Routes of Administration

    6.4. Global Peripheral Artery Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Hospitals

    Specialty Clinics

    Other End Users

    7. Peripheral Artery Disease Market Regional And Country Analysis

    7.1. Global Peripheral Artery Disease Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global Peripheral Artery Disease Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific Peripheral Artery Disease Market

    8.1. Asia-Pacific Peripheral Artery Disease Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific Peripheral Artery Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China Peripheral Artery Disease Market

    9.1. China Peripheral Artery Disease Market Overview

    9.2. China Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China Peripheral Artery Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India Peripheral Artery Disease Market

    10.1. India Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India Peripheral Artery Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan Peripheral Artery Disease Market

    11.1. Japan Peripheral Artery Disease Market Overview

    11.2. Japan Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan Peripheral Artery Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia Peripheral Artery Disease Market

    12.1. Australia Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia Peripheral Artery Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia Peripheral Artery Disease Market

    13.1. Indonesia Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia Peripheral Artery Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea Peripheral Artery Disease Market

    14.1. South Korea Peripheral Artery Disease Market Overview

    14.2. South Korea Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea Peripheral Artery Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe Peripheral Artery Disease Market

    15.1. Western Europe Peripheral Artery Disease Market Overview

    15.2. Western Europe Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe Peripheral Artery Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK Peripheral Artery Disease Market

    16.1. UK Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK Peripheral Artery Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany Peripheral Artery Disease Market

    17.1. Germany Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany Peripheral Artery Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France Peripheral Artery Disease Market

    18.5. France Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.6. France Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.7. France Peripheral Artery Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy Peripheral Artery Disease Market

    19.9. Italy Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.10. Italy Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.11. Italy Peripheral Artery Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain Peripheral Artery Disease Market

    20.13. Spain Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.14. Spain Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.15. Spain Peripheral Artery Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe Peripheral Artery Disease Market

    21.1. Eastern Europe Peripheral Artery Disease Market Overview

    21.2. Eastern Europe Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe Peripheral Artery Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia Peripheral Artery Disease Market

    22.1. Russia Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia Peripheral Artery Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America Peripheral Artery Disease Market

    23.1. North America Peripheral Artery Disease Market Overview

    23.2. North America Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America Peripheral Artery Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA Peripheral Artery Disease Market

    24.1. USA Peripheral Artery Disease Market Overview

    24.2. USA Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA Peripheral Artery Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada Peripheral Artery Disease Market

    25.1. Canada Peripheral Artery Disease Market Overview

    25.2. Canada Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada Peripheral Artery Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America Peripheral Artery Disease Market

    26.1. South America Peripheral Artery Disease Market Overview

    26.2. South America Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America Peripheral Artery Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil Peripheral Artery Disease Market

    27.1. Brazil Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil Peripheral Artery Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East Peripheral Artery Disease Market

    28.1. Middle East Peripheral Artery Disease Market Overview

    28.2. Middle East Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East Peripheral Artery Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa Peripheral Artery Disease Market

    29.1. Africa Peripheral Artery Disease Market Overview

    29.2. Africa Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa Peripheral Artery Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. Peripheral Artery Disease Market Competitive Landscape And Company Profiles

    30.1. Peripheral Artery Disease Market Competitive Landscape

    30.2. Peripheral Artery Disease Market Company Profiles

    30.2.1. Cardinal Health Inc.

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. Vascular Solutions Inc.

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. Bayer AG

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. Abbott Laboratories

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. Medtronic plc.

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. Peripheral Artery Disease Market Other Major And Innovative Companies

    31.1. Koninklijke Philips N.V. (Royal Philips)

    31.2. B. Braun Melsungen AG.

    31.3. Terumo Corporation

    31.4. Edwards Lifesciences

    31.5. Becton Dickinson and Company (BD)

    31.6. Boston Scientific Corporation Incorporated

    31.7. Cook Group Incorporated

    31.8. Merit Medical Systems Inc.

    31.9. NuVasive Inc.

    31.10. Arjo AB

    31.11. Penumbra Inc.

    31.12. BIOTRONIK SE and Co. KG

    31.13. Natus Medical Inc.

    31.14. AngioDynamics Inc.

    31.15. Shockwave Medical Inc.

    32. Global Peripheral Artery Disease Market Competitive Benchmarking

    33. Global Peripheral Artery Disease Market Competitive Dashboard

    34. Key Mergers And Acquisitions In The Peripheral Artery Disease Market

    35. Peripheral Artery Disease Market Future Outlook and Potential Analysis

    35.1 Peripheral Artery Disease Market In 2028 - Countries Offering Most New Opportunities

    35.2 Peripheral Artery Disease Market In 2028 - Segments Offering Most New Opportunities

    35.3 Peripheral Artery Disease Market In 2028 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global Peripheral Artery Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global Peripheral Artery Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global Peripheral Artery Disease Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Global Peripheral Artery Disease Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Asia-Pacific, Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: Asia-Pacific, Peripheral Artery Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: China, Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: China, Peripheral Artery Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: India, Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: India, Peripheral Artery Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: Japan, Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Japan, Peripheral Artery Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Australia, Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Australia, Peripheral Artery Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Indonesia, Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: Indonesia, Peripheral Artery Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: South Korea, Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: South Korea, Peripheral Artery Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: Western Europe, Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: Western Europe, Peripheral Artery Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: UK, Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: UK, Peripheral Artery Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: Germany, Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: Germany, Peripheral Artery Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: France, Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: France, Peripheral Artery Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: Italy, Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Italy, Peripheral Artery Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Spain, Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Spain, Peripheral Artery Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Eastern Europe, Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Eastern Europe, Peripheral Artery Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Russia, Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: Russia, Peripheral Artery Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: North America, Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: North America, Peripheral Artery Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: USA, Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: USA, Peripheral Artery Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: Canada, Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: Canada, Peripheral Artery Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: South America, Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: South America, Peripheral Artery Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: Brazil, Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Brazil, Peripheral Artery Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Middle East, Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Middle East, Peripheral Artery Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Africa, Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: Africa, Peripheral Artery Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 75: Cardinal Health Inc. Financial Performance
  • Table 76: Vascular Solutions Inc. Financial Performance
  • Table 77: Bayer AG Financial Performance
  • Table 78: Abbott Laboratories Financial Performance
  • Table 79: Medtronic plc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global Peripheral Artery Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global Peripheral Artery Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global Peripheral Artery Disease Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Global Peripheral Artery Disease Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Asia-Pacific, Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: Asia-Pacific, Peripheral Artery Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: China, Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: China, Peripheral Artery Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: India, Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: India, Peripheral Artery Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: Japan, Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Japan, Peripheral Artery Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Australia, Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Australia, Peripheral Artery Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Indonesia, Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: Indonesia, Peripheral Artery Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: South Korea, Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: South Korea, Peripheral Artery Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: Western Europe, Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: Western Europe, Peripheral Artery Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: UK, Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: UK, Peripheral Artery Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: Germany, Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: Germany, Peripheral Artery Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: France, Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: France, Peripheral Artery Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: Italy, Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Italy, Peripheral Artery Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Spain, Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Spain, Peripheral Artery Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Eastern Europe, Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Eastern Europe, Peripheral Artery Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Russia, Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: Russia, Peripheral Artery Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: North America, Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: North America, Peripheral Artery Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: USA, Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: USA, Peripheral Artery Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: Canada, Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: Canada, Peripheral Artery Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: South America, Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: South America, Peripheral Artery Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: Brazil, Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Brazil, Peripheral Artery Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Middle East, Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Middle East, Peripheral Artery Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Africa, Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: Africa, Peripheral Artery Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 75: Cardinal Health Inc. Financial Performance
  • Figure 76: Vascular Solutions Inc. Financial Performance
  • Figure 77: Bayer AG Financial Performance
  • Figure 78: Abbott Laboratories Financial Performance
  • Figure 79: Medtronic plc. Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report

Frequently Asked Questions

What is the definition of the peripheral artery disease market?

Peripheral artery disease (PAD) is a disorder that causes the arteries that carry blood to the limbs, most commonly the legs, to thin or block. It is usually caused by atherosclerosis, characterized by the accumulation of fatty deposits (plaques) inside the artery walls, resulting in decreased blood flow to the afflicted regions. For further insights on the peripheral artery disease market, request a sample here

How will the peripheral artery disease market drivers and restraints affect the peripheral artery disease market dynamics? What forces will shape the peripheral artery disease industry going forward?

The peripheral artery disease market major growth driver - Rising Prevalence Of Peripheral Artery Diseases Expected To Drive Growth In Peripheral Artery Disease Market. For further insights on the peripheral artery disease market, request a sample here

What is the forecast market size or the forecast market value of the peripheral artery disease market?

The peripheral artery disease market size has grown strongly in recent years. It will grow from $3.97 billion in 2023 to $4.28 billion in 2024 at a compound annual growth rate (CAGR) of 7.9%. The growth in the historic period can be attributed to increasing prevalence of risk factors, growing aging population, clinical research and evidence-based medicine, awareness and screening programs, government healthcare initiatives.. The peripheral artery disease market size is expected to see strong growth in the next few years. It will grow to $5.67 billion in 2028 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to focus on patient-centric care, advancements in minimally invasive procedures, digital health and remote monitoring, regenerative medicine approaches, targeted drug therapies.. Major trends in the forecast period include health equity initiatives, integration of wearable devices, expansion of home-based rehabilitation, patient-reported outcomes (pros), shift to outpatient settings.. For further insights on the peripheral artery disease market, request a sample here

How is the peripheral artery disease market segmented?

The peripheral artery disease market is segmented
1) By Type: Peripheral Angioplasty Balloons, Peripheral Stents, Peripheral Catheters, Inferior Vena Cava (IVC) Filters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Peripheral Accessories
2) By Drugs: Lipid-Lowering Drugs, Blood Pressure Lowering Drugs, Glucose Regulating Drugs, Blood Clot Preventing Drugs, Inotropes, Thrombolytics Agents, Anti-Inflammatory Agents
3) By Route of Administration: Oral, Parenteral, Other Routes of Administration
4) By End Users: Hospitals, Specialty Clinics, Other End UsersFor further insights on the peripheral artery disease market,
request a sample here

Which region has the largest share of the peripheral artery disease market? What are the other regions covered in the report?

North America was the largest region in the peripheral artery disease market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the peripheral artery disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the peripheral artery disease market, request a sample here.

Who are the major players in the peripheral artery disease market?

Major companies operating in the peripheral artery disease market report are Cardinal Health Inc., Vascular Solutions Inc., Bayer AG, Abbott Laboratories, Medtronic plc., Koninklijke Philips N.V. (Royal Philips), B. Braun Melsungen AG., Terumo Corporation, Edwards Lifesciences, Becton Dickinson and Company (BD), Boston Scientific Corporation Incorporated, Cook Group Incorporated, Merit Medical Systems Inc., NuVasive Inc., Arjo AB, Penumbra Inc., BIOTRONIK SE and Co. KG, Natus Medical Inc., AngioDynamics Inc., Shockwave Medical Inc., Cardiovascular Systems Inc., Endologix LLC., LeMaitre Vascular Inc., Silk Road Medical Inc., WL Gore and Associates Inc., MicroPort Scientific Corporation, Bard Peripheral Vascular Inc., Lombard Medical Inc., Avinger Inc., Ra Medical Systems Inc. For further insights on the peripheral artery disease market, request a sample here.

What are the key trends in the peripheral artery disease market?

Major trend in the peripheral artery disease market - Technologically Advanced Solution For Peripheral Artery Disease Treatment. For further insights on the peripheral artery disease market, request a sample here.

What are the major opportunities in the peripheral artery disease market? What are the strategies for the peripheral artery disease market?

For detailed insights on the major opportunities and strategies in the peripheral artery disease market, request a sample here.

How does the peripheral artery disease market relate to the overall economy and other similar markets?

For detailed insights on peripheral artery disease market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the peripheral artery disease industry?

For detailed insights on the mergers and acquisitions in the peripheral artery disease industry, request a sample here.

What are the key dynamics influencing the peripheral artery disease market growth? SWOT analysis of the peripheral artery disease market.

For detailed insights on the key dynamics influencing the peripheral artery disease market growth and SWOT analysis of the peripheral artery disease industry, request a sample here.